Company / Gross Profit
Enovis Gross Profit History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$1.3B
FY2025
5-year range
$603.6M / $1.3B
FY2021-FY2025
Trend
+13.9%
vs FY2024
Sector context
#33 of 100
Health Care
What the data says
At $1.3B, Enovis's gross profit ranks #33 of 100 in the Health Care sector. Gross Profit has increased for 3 consecutive years, from $604M in FY2022 to $1.3B in FY2025.
Based on SEC 10-K filings.
$1.3B in FY2025 with a 5-year CAGR of +13.0%.
Improved from $778M to $1.3B over the past 2 years.
Health Care sector context is included.
Gross Profit over time
Growth rates
- 3-Year CAGR
- +30.6%
- 5-Year CAGR
- +13.0%
- 10-Year CAGR
- -
Sector benchmark
#33 of 100 in Health CareTop 33% of 100This company $1.3B Sector average $1.8B
▼
-26.0% below sector average
Key checks
Key Insights
- Enovis's gross profit has grown for 3 consecutive years.
- 5-year CAGR of +13.0%, indicating consistent growth.
- In FY2025, gross profit increased 13.9% year-over-year.
- Ranks #33 out of 100 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.3B | +13.9% |
| FY2024 | $1.2B | +51.8% |
| FY2023 | $777.7M | +28.8% |
| FY2022 | $603.6M | -22.4% |
| FY2021 | $777.7M | +6.6% |
| FY2020 | $729.4M | +8.6% |
| FY2019 | $671.6M | -7.9% |
| FY2018 | $729.4M | -31.9% |
| FY2017 | $1.1B | +8.0% |
| FY2016 | $992.4M | -24.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026